SCHEMBL2532619

SCHEMBL2532619

CC1(C)[C@](C)(C=O)CC[C@]1(C)C(=O)O

nearest known ligand 0.37

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19285209 0.86 FFAR3 (0.40) FFAR3
SCHEMBL13635919 0.78 FFAR3 (0.50) FFAR3
SCHEMBL12073645 0.74 FFAR3 (0.37) FFAR3
SCHEMBL14439315 0.72 FFAR3 (0.56) FFAR3
SCHEMBL9152850 0.72 FFAR3 (0.56) FFAR3
SCHEMBL9152847 0.72 FFAR3 (0.56) FFAR3
SCHEMBL1335666 0.68 FFAR3 (0.40) FFAR3
SCHEMBL28783711 0.67 FFAR3 (0.39) FFAR3
SCHEMBL28200468 0.67 FFAR3 (0.39) FFAR3
SCHEMBL29064032 0.66 FFAR3 (0.48) FFAR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110257164-A1 DIPEPTIDYL PEPTIDASE IV INHIBITORS ORCHID RESEARCH LABORATORIES LIMITED (IN) 2011-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257164-A1 DIPEPTIDYL PEPTIDASE IV INHIBITORS DPP4, DPP7, DPP3 FFAR3 17/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.